Arena Pharmaceuticals Inc $6.18

down -0.12


17/4/2014 08:10 PM  |  NASDAQ : ARNA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ARNA Trend Analysis - it has underperformed the S&P 500 by 43%

Partner Headlines

  1. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving ...

    Benzinga
  2. Benzinga's Top #PreMarket Losers

    Benzinga
  3. Earnings Scheduled For February 27, 2014

    Benzinga
  4. Bad Earnings Weigh In On Diet Stocks

    Benzinga
  5. Top Trending Tickers On StockTwits For February 14

    Benzinga
  6. #PreMarket Primer: Friday, February 14: A Turnaround

    Benzinga
  7. Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® ...

    Benzinga
  8. Celgene To Release Earnings At J.P. Morgan Event Mon.

    IBD
  9. The Top Five Drug Launches Of 2013

    IBD
  10. (ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial ...

    GuruFocus
  11. Benzinga's Top #PreMarket Gainers

    Benzinga
  12. Market Wrap For November 11: Relative Quiet as Traders and Investors Observe ...

    Benzinga
  13. Market Wrap For November 8: Markets Erase Thursday's Losses; Dow Companies ...

    Benzinga
  14. Arena Pharmaceuticals, Eisai Expand Marketing and Supply Agreement for ...

    Benzinga
  15. Nasdaq Leads Stocks Lower; Twitter IPO Opens To 80% Gain

    IBD
  16. How Arena’s “$3 Billion” Belviq Withered

    YCharts
  17. Benzinga's Top #PreMarket Losers

    Benzinga
  18. Market Wrap For Tuesday, October 15: Earnings Reports And White House Progress ...

    Benzinga
  19. Mid-Afternoon Market Update: Tumi Holdings Rises Amid Market Decline

    Benzinga
  20. Mid-Morning Market Update: Markets Slip; Citigroup Profit Misses Estimates

    Benzinga
  21. UPDATE: Arena Says Eisai Will Double BELVIQ Sales Force to 400 Reps

    Benzinga
  22. Vivus Weighs In As a Leader for Diet Pills, Cowen Upgrades and Raises PT

    Benzinga
  23. Obesity Drug Stocks Jump As Cowen Gets Bullish

    IBD
  24. Benzinga's Top Pre-Market Losers

    Benzinga
  25. Market Wrap For September 30: Debt Ceiling And Government Shutdown Loom

    Benzinga
  26. Mid-Afternoon Market Update: Mellanox Rallies As Market Remains in the ...

    Benzinga
  27. Mid-Day Market Update: Dow Falls Over 100 Points; Active Network Shares ...

    Benzinga
  28. Mid-Morning Market Update: Markets Open Lower; Cal-Maine Q1 Net Profit ...

    Benzinga
  29. UPDATE: Credit Suisse Lowers PT on Arena Pharmaceuticals Following Management ...

    Benzinga
  30. Arena Pharma Offers Update on Eisai Launch of BELVIQ, Says Placing Ads ...

    Benzinga
  31. Stocks Hitting 52-Week Lows

    Benzinga
  32. BMO Considers Recent Sales Data on Arena's Belviq, Maintains Market Perform ...

    Benzinga
  33. CEO Shift Aside, Whose Weight-Loss Pill’s Ahead

    YCharts
  34. Stocks Hitting 52-Week Lows

    Benzinga
  35. Stocks Hitting 52-Week Lows

    Benzinga
  36. Arena Pharma Reports Closing of Phase 1b Clinical Trial for APD811

    Benzinga
  37. Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)

    Benzinga
  38. It's Hard to Sell a Pill That Nobody's Heard Of

    YCharts
  39. Weekly Preview: Earnings Season Continues, Fed In Focus, Economic Maelstrom ...

    Benzinga
  40. Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC)

    Benzinga
  41. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  42. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  43. Mid-Afternoon Market Update: Markets All Green, Research in Motion Looks ...

    Benzinga
  44. Mid-Day Market Update: GenCorp Rises, Markets Erasing Losses

    Benzinga
  45. Mid-Morning Market Update: Verizon Misses Big on Earnings, Research in ...

    Benzinga
  46. Vivus fell 4.2% to 13.72

    IBD
  47. Vivus Stock Drops On Downgrade; Rival Arena Rises

    IBD
  48. Measuring Social Network Buzz Over Pharma Stocks

    YCharts
  49. Vivus Stock Jumps On Latest Qsymia Shipment Numbers

    IBD
  50. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga
Trading Center